SCHEMBL3054451

SCHEMBL3054451

O=C(O)C(Cc1ccccc1)N1C(=O)C(=Cc2ccc(OCc3ccccc3)c(C(=O)N(Cc3ccccc3)Cc3ccccc3)c2)SC1=S

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 3/20 0.77
MAPT P10636 7/20 0.62
BCL2 P10415 5/20 0.62
BCL2L2 Q92843 5/20 0.62
BAD Q92934 5/20 0.62
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
POLB P06746 2/20 0.61
MAPK1 P28482 1/20 0.61
RECQL P46063 1/20 0.61
MME P08473 2/20 0.60
PLA2G1B P04054 1/20 0.60
ATG4B Q9Y4P1 1/20 0.60
ALDH1A1 P00352 3/20 0.59
CRHBP P24387 1/20 0.59
CRHR2 Q13324 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
PTPN1 P18031 2/20 0.58
MCL1 Q07820 1/20 0.56
BAK1 Q16611 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5218101 0.87 ADAMTS5 (1.00) ADAMTS5MAPTBCL2BCL2L2BAD
SCHEMBL2932379 0.84 ADAMTS5 (0.75) ADAMTS5PTPN1
SCHEMBL19430434 0.78 MAPT (1.00) ADAMTS5MAPTBCL2BCL2L2BAD
SCHEMBL6806720 0.77 ADAMTS5 (0.75) ADAMTS5PTPN1
SCHEMBL2932473 0.77 ADAMTS5 (0.67) ADAMTS5PTPN1
SCHEMBL13846498 0.76 MAPT (0.87) ADAMTS5MAPTBCL2BCL2L2BAD
SCHEMBL6888325 0.76 ADAMTS5 (0.76) ADAMTS5MAPTMEN1KMT2APOLB
SCHEMBL6888323 0.76 ADAMTS5 (0.76) ADAMTS5MAPTMEN1KMT2APOLB
SCHEMBL2932645 0.75 ADAMTS5 (0.72) ADAMTS5PTPN1
SCHEMBL7149409 0.75 ADAMTS5 (0.68) ADAMTS5MAPTBCL2BCL2L2BAD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313731-B1 THIAZOLIDINE DERIVATIVES AND ITS USE AS ANTIFUNGAL AGENT UCB SA (BE) 2010-09-29 EP disclosed
US-6740670-B2 SUCH AS 5-(((3-(N-METHYL-N-PHENYLAMINO)CARBONYL-4-(PHENYL-METHOXY)) -PHENYL)METHYLENE)-4-OXO-2-THIOXO-3-THIAZOLIDINE-ACETIC ACID OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2004-05-25 US disclosed
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent OXFORD GLYCOSCIENCES (UK) LTD (GB) 2003-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent CYP3A7, TAS2R7, OXSR1 ADAMTS5 4728/4885MAPT 3925/4885BCL2 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.